Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retina | 12 | 2025 | 461 | 2.510 |
Why?
|
| Microglia | 5 | 2025 | 138 | 2.260 |
Why?
|
| Retinal Ganglion Cells | 6 | 2025 | 117 | 2.130 |
Why?
|
| West Nile virus | 18 | 2012 | 118 | 2.120 |
Why?
|
| Neurons | 15 | 2023 | 1990 | 1.640 |
Why?
|
| Synapses | 7 | 2022 | 445 | 1.470 |
Why?
|
| West Nile Fever | 14 | 2012 | 139 | 1.380 |
Why?
|
| Neurites | 2 | 2020 | 45 | 1.300 |
Why?
|
| Photoreceptor Cells | 2 | 2021 | 91 | 1.290 |
Why?
|
| Central Nervous System | 6 | 2023 | 285 | 1.070 |
Why?
|
| Neuroglia | 2 | 2024 | 223 | 0.910 |
Why?
|
| Myoclonic Epilepsies, Progressive | 2 | 2022 | 13 | 0.910 |
Why?
|
| AMP-Activated Protein Kinases | 4 | 2025 | 173 | 0.890 |
Why?
|
| Vision, Ocular | 2 | 2021 | 127 | 0.790 |
Why?
|
| CD47 Antigen | 1 | 2022 | 11 | 0.770 |
Why?
|
| Potassium Channels | 2 | 2022 | 156 | 0.740 |
Why?
|
| Neurodegenerative Diseases | 1 | 2025 | 289 | 0.740 |
Why?
|
| Dopamine | 1 | 2023 | 256 | 0.730 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 119 | 0.730 |
Why?
|
| Cell Movement | 2 | 2025 | 875 | 0.710 |
Why?
|
| Animals | 37 | 2025 | 34321 | 0.700 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 341 | 0.690 |
Why?
|
| Complement C1q | 1 | 2020 | 18 | 0.670 |
Why?
|
| Mice, Knockout | 14 | 2025 | 3860 | 0.660 |
Why?
|
| Purkinje Cells | 1 | 2022 | 170 | 0.660 |
Why?
|
| Strategic Planning | 1 | 2019 | 6 | 0.630 |
Why?
|
| Retinal Neurons | 1 | 2019 | 14 | 0.620 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2022 | 397 | 0.620 |
Why?
|
| Mice | 25 | 2025 | 18464 | 0.590 |
Why?
|
| Neuronal Plasticity | 2 | 2022 | 288 | 0.590 |
Why?
|
| Retinal Vessels | 1 | 2019 | 52 | 0.590 |
Why?
|
| Laboratories | 1 | 2019 | 84 | 0.590 |
Why?
|
| Organizational Culture | 1 | 2019 | 94 | 0.580 |
Why?
|
| Personnel Selection | 1 | 2019 | 79 | 0.570 |
Why?
|
| Neurogenesis | 1 | 2020 | 224 | 0.550 |
Why?
|
| Career Choice | 1 | 2019 | 161 | 0.550 |
Why?
|
| Research Personnel | 1 | 2019 | 139 | 0.550 |
Why?
|
| Signal Transduction | 3 | 2025 | 4666 | 0.480 |
Why?
|
| Aging | 2 | 2014 | 1261 | 0.460 |
Why?
|
| Rod Cell Outer Segment | 1 | 2014 | 45 | 0.430 |
Why?
|
| Brain | 2 | 2025 | 3234 | 0.420 |
Why?
|
| Virus Replication | 6 | 2012 | 597 | 0.400 |
Why?
|
| Agrin | 1 | 2012 | 1 | 0.390 |
Why?
|
| Laminin | 1 | 2012 | 68 | 0.370 |
Why?
|
| Neuromuscular Junction | 1 | 2012 | 96 | 0.370 |
Why?
|
| Retinal Horizontal Cells | 2 | 2021 | 12 | 0.340 |
Why?
|
| Visual Pathways | 1 | 2011 | 80 | 0.340 |
Why?
|
| Interferon-alpha | 4 | 2008 | 241 | 0.340 |
Why?
|
| Mice, Inbred C57BL | 12 | 2019 | 4761 | 0.340 |
Why?
|
| Phagocytosis | 2 | 2022 | 191 | 0.330 |
Why?
|
| Interferon-beta | 3 | 2007 | 56 | 0.310 |
Why?
|
| Paralysis | 1 | 2007 | 29 | 0.270 |
Why?
|
| Axonal Transport | 1 | 2007 | 27 | 0.270 |
Why?
|
| Virus Internalization | 1 | 2007 | 59 | 0.270 |
Why?
|
| Immunity, Innate | 2 | 2009 | 411 | 0.260 |
Why?
|
| Macrophages | 5 | 2022 | 663 | 0.260 |
Why?
|
| Electroretinography | 2 | 2019 | 107 | 0.260 |
Why?
|
| Encephalitis, Viral | 1 | 2006 | 21 | 0.250 |
Why?
|
| Retinal Bipolar Cells | 2 | 2019 | 41 | 0.250 |
Why?
|
| Caspase 3 | 1 | 2006 | 126 | 0.250 |
Why?
|
| Muscle Hypotonia | 1 | 2007 | 194 | 0.250 |
Why?
|
| Meningoencephalitis | 1 | 2006 | 20 | 0.250 |
Why?
|
| eIF-2 Kinase | 1 | 2006 | 35 | 0.250 |
Why?
|
| Endoribonucleases | 1 | 2006 | 84 | 0.240 |
Why?
|
| Blood-Brain Barrier | 1 | 2025 | 149 | 0.220 |
Why?
|
| Retinal Cone Photoreceptor Cells | 2 | 2021 | 76 | 0.210 |
Why?
|
| Amacrine Cells | 2 | 2014 | 42 | 0.190 |
Why?
|
| Cell Survival | 1 | 2025 | 853 | 0.190 |
Why?
|
| Antigens, Differentiation | 1 | 2022 | 63 | 0.190 |
Why?
|
| Microscopy, Fluorescence | 2 | 2022 | 312 | 0.180 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2022 | 89 | 0.180 |
Why?
|
| Humans | 15 | 2025 | 131410 | 0.180 |
Why?
|
| RNA, Messenger | 5 | 2019 | 2568 | 0.170 |
Why?
|
| Complement C3a | 1 | 2020 | 18 | 0.170 |
Why?
|
| Receptors, Complement | 1 | 2020 | 31 | 0.170 |
Why?
|
| Vesicular Glutamate Transport Protein 1 | 1 | 2020 | 14 | 0.160 |
Why?
|
| Apoptosis | 1 | 2006 | 1862 | 0.160 |
Why?
|
| Interneurons | 1 | 2021 | 146 | 0.150 |
Why?
|
| Protein Transport | 1 | 2020 | 362 | 0.150 |
Why?
|
| Neuropil | 1 | 2018 | 10 | 0.140 |
Why?
|
| Superior Cervical Ganglion | 2 | 2007 | 4 | 0.130 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 83 | 0.130 |
Why?
|
| Seizures | 1 | 2022 | 887 | 0.130 |
Why?
|
| Mutagenesis | 1 | 2018 | 334 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 1236 | 0.130 |
Why?
|
| Cells, Cultured | 6 | 2008 | 2970 | 0.130 |
Why?
|
| Axons | 2 | 2011 | 385 | 0.130 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 206 | 0.130 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 1610 | 0.120 |
Why?
|
| Substrate Specificity | 2 | 2014 | 286 | 0.120 |
Why?
|
| Organ Specificity | 2 | 2006 | 400 | 0.110 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 420 | 0.110 |
Why?
|
| Phenotype | 3 | 2022 | 4516 | 0.110 |
Why?
|
| Antiviral Agents | 4 | 2008 | 812 | 0.110 |
Why?
|
| Interferon-gamma | 2 | 2006 | 542 | 0.100 |
Why?
|
| Cricetinae | 3 | 2007 | 367 | 0.100 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2012 | 102 | 0.090 |
Why?
|
| Junctional Adhesion Molecule B | 1 | 2011 | 3 | 0.090 |
Why?
|
| Thy-1 Antigens | 1 | 2011 | 19 | 0.090 |
Why?
|
| Motor Neurons | 1 | 2012 | 131 | 0.090 |
Why?
|
| Male | 5 | 2020 | 65108 | 0.090 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2011 | 41 | 0.090 |
Why?
|
| Viral Load | 3 | 2008 | 406 | 0.090 |
Why?
|
| Luminescent Proteins | 1 | 2011 | 157 | 0.090 |
Why?
|
| Immunoglobulins | 1 | 2011 | 159 | 0.090 |
Why?
|
| Patch-Clamp Techniques | 1 | 2011 | 279 | 0.080 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 2363 | 0.080 |
Why?
|
| Mutation | 2 | 2020 | 6177 | 0.080 |
Why?
|
| Female | 5 | 2020 | 71030 | 0.080 |
Why?
|
| Phosphorylation | 1 | 2014 | 1569 | 0.080 |
Why?
|
| RNA, Viral | 2 | 2010 | 513 | 0.080 |
Why?
|
| Membrane Potentials | 1 | 2011 | 297 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 227 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2011 | 824 | 0.080 |
Why?
|
| RNA Virus Infections | 1 | 2010 | 7 | 0.080 |
Why?
|
| Eye Proteins | 1 | 2011 | 234 | 0.080 |
Why?
|
| Dendrites | 1 | 2011 | 181 | 0.080 |
Why?
|
| Invertebrates | 1 | 2010 | 6 | 0.080 |
Why?
|
| Vertebrates | 1 | 2010 | 39 | 0.080 |
Why?
|
| Armadillo Domain Proteins | 1 | 2009 | 8 | 0.080 |
Why?
|
| Astrocytes | 1 | 2012 | 288 | 0.080 |
Why?
|
| Animals, Newborn | 2 | 2018 | 1024 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2011 | 769 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2012 | 536 | 0.070 |
Why?
|
| Brain Stem | 1 | 2009 | 112 | 0.070 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2008 | 20 | 0.070 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2008 | 9 | 0.070 |
Why?
|
| Risk Factors | 1 | 2023 | 10947 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 1 | 2009 | 279 | 0.070 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2007 | 18 | 0.070 |
Why?
|
| Mesocricetus | 1 | 2007 | 69 | 0.070 |
Why?
|
| Genes, Reporter | 2 | 2006 | 350 | 0.070 |
Why?
|
| Virion | 1 | 2007 | 116 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 2 | 2006 | 382 | 0.070 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 261 | 0.060 |
Why?
|
| Cerebral Cortex | 2 | 2008 | 468 | 0.060 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2006 | 97 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 642 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2008 | 460 | 0.060 |
Why?
|
| Cerebellar Cortex | 1 | 2006 | 20 | 0.060 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2006 | 19 | 0.060 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2005 | 20 | 0.060 |
Why?
|
| Antigens, Viral | 1 | 2007 | 396 | 0.060 |
Why?
|
| Viscera | 1 | 2005 | 55 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2006 | 588 | 0.060 |
Why?
|
| Chemokines, CXC | 1 | 2005 | 36 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 1123 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2006 | 95 | 0.060 |
Why?
|
| Disease Susceptibility | 1 | 2006 | 283 | 0.060 |
Why?
|
| Age Factors | 1 | 2011 | 2869 | 0.060 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2006 | 140 | 0.060 |
Why?
|
| Interferons | 1 | 2005 | 136 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 1148 | 0.050 |
Why?
|
| Spleen | 1 | 2005 | 256 | 0.050 |
Why?
|
| Cytomegalovirus | 1 | 2006 | 258 | 0.050 |
Why?
|
| DNA, Viral | 1 | 2006 | 451 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2005 | 266 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2006 | 421 | 0.050 |
Why?
|
| Arginine | 1 | 2006 | 343 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 2354 | 0.050 |
Why?
|
| Cell Line | 4 | 2012 | 2604 | 0.050 |
Why?
|
| Opsins | 1 | 2021 | 4 | 0.050 |
Why?
|
| Rod Opsins | 1 | 2021 | 17 | 0.050 |
Why?
|
| Child | 1 | 2022 | 26224 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2006 | 739 | 0.040 |
Why?
|
| Rats | 1 | 2007 | 3454 | 0.040 |
Why?
|
| Mammals | 1 | 2021 | 258 | 0.040 |
Why?
|
| Vero Cells | 2 | 2012 | 114 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2005 | 990 | 0.040 |
Why?
|
| Fibroblasts | 3 | 2008 | 864 | 0.040 |
Why?
|
| Rabbits | 1 | 2018 | 633 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2005 | 1775 | 0.030 |
Why?
|
| Dendritic Cells | 2 | 2008 | 439 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2008 | 1522 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2021 | 1614 | 0.030 |
Why?
|
| Microvessels | 1 | 2012 | 65 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2006 | 3613 | 0.020 |
Why?
|
| Antibodies, Viral | 2 | 2008 | 1169 | 0.020 |
Why?
|
| Aged | 1 | 2009 | 21215 | 0.020 |
Why?
|
| RNA Viruses | 1 | 2010 | 32 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2009 | 82 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2009 | 366 | 0.020 |
Why?
|
| Cell Death | 1 | 2009 | 237 | 0.020 |
Why?
|
| Mice, Congenic | 1 | 2008 | 17 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2008 | 155 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 665 | 0.020 |
Why?
|
| Viremia | 1 | 2008 | 132 | 0.020 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2007 | 51 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2007 | 152 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2007 | 125 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2007 | 230 | 0.020 |
Why?
|
| STAT Transcription Factors | 1 | 2006 | 25 | 0.020 |
Why?
|
| Drug Design | 1 | 2007 | 166 | 0.020 |
Why?
|
| Artificial Gene Fusion | 1 | 2006 | 11 | 0.020 |
Why?
|
| Furin | 1 | 2006 | 6 | 0.020 |
Why?
|
| Nucleoside-Triphosphatase | 1 | 2006 | 21 | 0.020 |
Why?
|
| Bacteriophage phi X 174 | 1 | 2005 | 4 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2008 | 448 | 0.020 |
Why?
|
| Perforin | 1 | 2006 | 26 | 0.020 |
Why?
|
| Serpins | 1 | 2006 | 34 | 0.010 |
Why?
|
| Salmonella | 1 | 2005 | 31 | 0.010 |
Why?
|
| Receptors, CXCR3 | 1 | 2005 | 22 | 0.010 |
Why?
|
| Receptors, Chemokine | 1 | 2005 | 47 | 0.010 |
Why?
|
| Capsid | 1 | 2005 | 96 | 0.010 |
Why?
|
| CD8 Antigens | 1 | 2005 | 39 | 0.010 |
Why?
|
| Epistasis, Genetic | 1 | 2005 | 98 | 0.010 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2006 | 233 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2006 | 225 | 0.010 |
Why?
|
| Chemokine CXCL10 | 1 | 2005 | 52 | 0.010 |
Why?
|
| RNA Helicases | 1 | 2006 | 76 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2006 | 280 | 0.010 |
Why?
|
| Selection, Genetic | 1 | 2005 | 157 | 0.010 |
Why?
|
| Myelin Sheath | 1 | 2006 | 127 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 624 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2006 | 199 | 0.010 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2006 | 162 | 0.010 |
Why?
|
| Interferon Type I | 1 | 2005 | 115 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2007 | 579 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 722 | 0.010 |
Why?
|
| Phylogeny | 1 | 2006 | 707 | 0.010 |
Why?
|
| Plasmids | 1 | 2005 | 455 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 1624 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2005 | 695 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 692 | 0.010 |
Why?
|
| Transfection | 1 | 2005 | 960 | 0.010 |
Why?
|
| Kinetics | 1 | 2005 | 1101 | 0.010 |
Why?
|
| Binding Sites | 1 | 2006 | 1203 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2005 | 492 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2010 | 894 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2005 | 751 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2005 | 658 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2005 | 1087 | 0.010 |
Why?
|
| Peptides | 1 | 2006 | 835 | 0.010 |
Why?
|
| Protein Binding | 1 | 2006 | 1710 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 2563 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 1312 | 0.010 |
Why?
|
| Gene Expression | 1 | 2005 | 1500 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2005 | 984 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 3671 | 0.010 |
Why?
|
| Genotype | 1 | 2005 | 2656 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2005 | 1008 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2005 | 1559 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 4683 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 3411 | 0.010 |
Why?
|